Gossamer Bio (GOSS) Debt to Equity (2022 - 2024)
Historic Debt to Equity for Gossamer Bio (GOSS) over the last 3 years, with Q1 2024 value amounting to $0.36.
- Gossamer Bio's Debt to Equity rose 14901.24% to $0.36 in Q1 2024 from the same period last year, while for Mar 2024 it was $0.36, marking a year-over-year increase of 14901.24%. This contributed to the annual value of $0.2 for FY2023, which is 8986.91% down from last year.
- Per Gossamer Bio's latest filing, its Debt to Equity stood at $0.36 for Q1 2024, which was up 14901.24% from $0.2 recorded in Q4 2023.
- In the past 5 years, Gossamer Bio's Debt to Equity ranged from a high of $1.95 in Q4 2022 and a low of -$1.07 during Q2 2022
- For the 3-year period, Gossamer Bio's Debt to Equity averaged around $0.2, with its median value being $0.2 (2023).
- In the last 5 years, Gossamer Bio's Debt to Equity crashed by 17570.49% in 2023 and then soared by 14901.24% in 2024.
- Gossamer Bio's Debt to Equity (Quarter) stood at $1.95 in 2022, then plummeted by 89.87% to $0.2 in 2023, then skyrocketed by 81.25% to $0.36 in 2024.
- Its Debt to Equity stands at $0.36 for Q1 2024, versus $0.2 for Q4 2023 and $0.15 for Q3 2023.